CN1066781A - 含有碳酸酐酶抑制剂和β-肾上腺素能拮抗物的眼用组合物 - Google Patents
含有碳酸酐酶抑制剂和β-肾上腺素能拮抗物的眼用组合物 Download PDFInfo
- Publication number
- CN1066781A CN1066781A CN92103682A CN92103682A CN1066781A CN 1066781 A CN1066781 A CN 1066781A CN 92103682 A CN92103682 A CN 92103682A CN 92103682 A CN92103682 A CN 92103682A CN 1066781 A CN1066781 A CN 1066781A
- Authority
- CN
- China
- Prior art keywords
- carbonic anhydrase
- beta
- preparation
- composition
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68671891A | 1991-04-17 | 1991-04-17 | |
US686,718 | 1991-04-17 | ||
US83491392A | 1992-02-13 | 1992-02-13 | |
US834,913 | 1992-02-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1066781A true CN1066781A (zh) | 1992-12-09 |
CN1073421C CN1073421C (zh) | 2001-10-24 |
Family
ID=27103852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN92103682A Expired - Lifetime CN1073421C (zh) | 1991-04-17 | 1992-04-16 | 含有碳酸酐酶抑制剂和β-肾上腺素能拮抗物的眼用组合物 |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0509752B1 (zh) |
JP (1) | JP2527513B2 (zh) |
KR (1) | KR920019348A (zh) |
CN (1) | CN1073421C (zh) |
AT (1) | ATE182787T1 (zh) |
AU (1) | AU648659C (zh) |
CA (1) | CA2065965C (zh) |
CH (1) | CH0509752H1 (zh) |
CY (1) | CY2146B1 (zh) |
CZ (1) | CZ285129B6 (zh) |
DE (3) | DE69229688C5 (zh) |
DK (1) | DK0509752T3 (zh) |
ES (1) | ES2133304T3 (zh) |
GR (1) | GR3031467T3 (zh) |
HK (1) | HK1009251A1 (zh) |
IE (1) | IE921240A1 (zh) |
IL (1) | IL101537A (zh) |
LU (1) | LU90506I2 (zh) |
MX (1) | MX9201785A (zh) |
NL (1) | NL990041I2 (zh) |
NO (1) | NO306196B1 (zh) |
RO (1) | RO113612B1 (zh) |
SK (1) | SK282039B6 (zh) |
WO (1) | WO1992018124A1 (zh) |
YU (1) | YU39392A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345594C (zh) * | 2004-01-19 | 2007-10-31 | 无锡杰西医药科技有限公司 | 乙酰唑胺滴眼液 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932572A (en) * | 1992-02-21 | 1999-08-03 | Alcon Laboratories, Inc. | Topical anti-glaucoma compositions |
AU677577B2 (en) * | 1992-02-21 | 1997-05-01 | Alcon Laboratories, Inc. | Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
US6071904A (en) * | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
FI981473A (fi) * | 1998-06-25 | 1999-12-26 | Orion Yhtymae Oyj | Menetelmä pulmonaalihypertension hoitamiseksi |
TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
US8211450B2 (en) * | 2010-05-05 | 2012-07-03 | Senju Usa, Inc. | Ophthalmic composition |
US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
AU2011282681B2 (en) | 2010-07-29 | 2015-07-30 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
JP5893204B1 (ja) * | 2015-02-23 | 2016-03-23 | 参天製薬株式会社 | 防腐効果のある医薬の組合せ |
JP6132968B1 (ja) * | 2016-01-29 | 2017-05-24 | 参天製薬株式会社 | ドルゾラミド、高分子およびホウ酸を含有する医薬組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863922A (en) * | 1984-12-12 | 1989-09-05 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
-
1992
- 1992-04-09 CZ CZ932098A patent/CZ285129B6/cs not_active IP Right Cessation
- 1992-04-09 SK SK1103-93A patent/SK282039B6/sk not_active IP Right Cessation
- 1992-04-09 RO RO93-01388A patent/RO113612B1/ro unknown
- 1992-04-09 WO PCT/US1992/002903 patent/WO1992018124A1/en active IP Right Grant
- 1992-04-09 IL IL101537A patent/IL101537A/xx not_active IP Right Cessation
- 1992-04-14 DK DK92303330T patent/DK0509752T3/da active
- 1992-04-14 ES ES92303330T patent/ES2133304T3/es not_active Expired - Lifetime
- 1992-04-14 EP EP92303330A patent/EP0509752B1/en not_active Expired - Lifetime
- 1992-04-14 CA CA002065965A patent/CA2065965C/en not_active Expired - Lifetime
- 1992-04-14 AT AT92303330T patent/ATE182787T1/de active
- 1992-04-14 DE DE69229688A patent/DE69229688C5/de not_active Expired - Lifetime
- 1992-04-14 DE DE2000175002 patent/DE10075002I2/de active Active
- 1992-04-14 DE DE69229688T patent/DE69229688T4/de not_active Expired - Lifetime
- 1992-04-14 CH CH92303330T patent/CH0509752H1/fr unknown
- 1992-04-15 MX MX9201785A patent/MX9201785A/es unknown
- 1992-04-15 YU YU39392A patent/YU39392A/sh unknown
- 1992-04-16 CN CN92103682A patent/CN1073421C/zh not_active Expired - Lifetime
- 1992-04-16 IE IE124092A patent/IE921240A1/en not_active IP Right Cessation
- 1992-04-16 KR KR1019920006335A patent/KR920019348A/ko not_active Application Discontinuation
- 1992-04-16 AU AU14979/92A patent/AU648659C/en not_active Expired
- 1992-04-17 JP JP4097956A patent/JP2527513B2/ja not_active Expired - Lifetime
-
1993
- 1993-10-15 NO NO933714A patent/NO306196B1/no not_active IP Right Cessation
-
1998
- 1998-08-12 HK HK98109871A patent/HK1009251A1/xx not_active IP Right Cessation
-
1999
- 1999-10-08 GR GR990402558T patent/GR3031467T3/el unknown
- 1999-12-01 NL NL990041C patent/NL990041I2/nl unknown
- 1999-12-29 CY CY9900045A patent/CY2146B1/xx unknown
-
2000
- 2000-01-19 LU LU90506C patent/LU90506I2/fr unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345594C (zh) * | 2004-01-19 | 2007-10-31 | 无锡杰西医药科技有限公司 | 乙酰唑胺滴眼液 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1178911C (zh) | 吡咯烷与哌啶衍生物和它们用于治疗神经变性疾病的用途 | |
CN1366881A (zh) | 用雌激素激动剂/拮抗剂治疗某些癌症的方法 | |
CN1617729A (zh) | 具有胆汁酸输送抑制活性的苯并噻氮䓬类在降低胆固醇血症中的应用 | |
CN1119099A (zh) | 对中枢神经系统具有药理活性的药物组合物的制备方法 | |
CN1555263A (zh) | 治疗普通感冒的组合物 | |
CN1646127A (zh) | 雷诺嗪在用于制备治疗心律失常药剂中的应用 | |
CN1678578A (zh) | 具有抗糖尿病活性的吲哚化合物 | |
CN1606439A (zh) | 顺式-2,4,5-三苯基-咪唑啉及其在肿瘤治疗中的应用 | |
CN1993346A (zh) | 新颖噻吩化合物 | |
CN1129443A (zh) | 仲胺用作治糖尿病和治肥胖病药物 | |
CN1182103C (zh) | 乙胺衍生物 | |
CN1059908A (zh) | 嘧啶衍生物及其药物 | |
CN1066781A (zh) | 含有碳酸酐酶抑制剂和β-肾上腺素能拮抗物的眼用组合物 | |
CN1345311A (zh) | 用于治疗中枢神经系统紊乱的1-芳基磺酰基-2-芳基-吡咯烷和派啶衍生物 | |
CN1011780B (zh) | 苯氧基乙酸衍生物的制备方法 | |
CN1520402A (zh) | 非对称环二胺化合物 | |
CN1774245A (zh) | 用于视网膜神经疾病的含有烷基醚衍生物或其盐的预防剂/治疗剂 | |
CN1921859A (zh) | 用于治疗骨疾病的吲哚衍生物 | |
CN1147469C (zh) | 带有芳香族含氮杂环的新型脲衍生物 | |
CN1254334A (zh) | 新颖的对苯二甲酰胺衍生物 | |
CN1270528A (zh) | 向精神药物 | |
CN1564687A (zh) | 磷酸二酯酶iv抑制剂的用途 | |
CN1296357C (zh) | 杂芳基取代的氨基环己烷衍生物 | |
CN1031754C (zh) | 制备二噻烷衍生物的方法 | |
CN1638763A (zh) | 抗抑郁剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
C56 | Change in the name or address of the patentee |
Owner name: MERCK & CO. INC. Free format text: FORMER NAME OR ADDRESS: MERCK + CO., INC. |
|
CP03 | Change of name, title or address |
Address after: New Jersey, USA Patentee after: Merk & Co. Inc. Address before: New Jersey, USA Patentee before: MERCK & Co.,Inc. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: New Jersey, USA Patentee after: Schering Corporation Address before: New Jersey, USA Patentee before: Merk & Co. Inc. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20120416 Granted publication date: 20011024 |